Romero-Cárdenas A, Vargas-Barrón J, Espinola-Zavaleta N, Roldan-Gómez FJ, Pérez-Soriano P

Language: Spanish
References: 12
Page: 209-220
PDF size: 96.58 Kb.

ABSTRACT

Objective: Identify risk factors associated with failures in myringoplasty. Material and Methods: 290 cases were reviewed in the period of july 1997 to march 1999. An analysis of cases and controls was performed. Results: The 290 myringoplasties were analyzed. The minimum period of follow-up was: 6 months. The estimated surgical success was 82.1%, and 17.9% of the cases were considered as a failure. There were no risk factors found statistically significant to the variables: age, sex, schooling or occupation of the patient, tobacco usage, alcoholism and associated illnesses; prior nasal or otological surgery or cause of the perforation nor evolution time whether or not it was a resident doctor who performed the surgery. These results are not definitives since the intervals of confidence were ample in the majority of these variables, which can be attributed to the size of the sample group. The significant risk variables found were: size of perforation greater than 40%, marginal localization of the perforation; tympanosclerosis, scar tissue and cholesteatoma. Conclusions: The risk factors in the myringoplasty failure are similar to those reported in diverse studies. The variables highly significant for failure are details that should be watched in the technique.

REFERENCES

1. Gramiak R, Sha PM. Echocardiography of the aortic root Invest Radiol 1968;3:356-66.

2. Reale A, Pizzuto F, Gioffre Pa, et al. Contrast echocardiography transmission of echoes to the left heart across the pulmonary vascular bed. Eur Heart J 1980;1:101-6

3. Metlzer RS, Serruys PW, McGhine J, Verbban N, Roelandt J. Pulmonary wedge injections yielding left-side, echocardiographic contrast. Br Heart J 1980;44:390-4

4. Bommer WJ, Ticker EG, Rasor J, Grehl t, Mason DT, De María AN. Development of a new echocardiographic contrast agent capable of pulmonary transmission and left heart opacification following peripheral venous injection (abstr). Circulation 1980;62(suppl III):III-34.

5. Meltzer RS, Tickner EG, Shaines TP, Popp RL. Transmission of echocardiographic contrast through the lungs. Ultrasound Med Biol 1981;7:377-84

6. Feinstein SB, Ten Cate FJ, Zwhel W, et al. Two-dimensional contrast echocardiography. I. in vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol 1984;3:14-20..

7. 7 Cheirif J, Yamamoto H, Zoghbi WA, Henry PD, Quiñones MA. Demonstration of physiological transit time of sonicated meglumine diatrizoate in microvascular preparation. J Cardiovasc Ultarsonogr 1987;6:245-247.

8. Levine RA, Teichholz LE, Goldman ME, Steinmetz MY, Baker M, Metzer RS. Microbubbles have intracardiac velocities similar to those of red blood cells. J Am Coll Cardiol 1984;33:728-33.

9. Nanda NC, Schlief R. Advances in Echo imaging using contrast enhancement. Kluwer Academic Publishing. Dordrecht. The Netherlands, 1993:309-23.

10. Newman JH, Ross JR. Chronic cor pulmonale. En: Hurst's .The Heart. Ajexander RW, Schlant RC, Fuster V. (Eds). McGraw-Hill Inc 9a. Edición New York. 1998,pp 1739-1749.

11. Shapiro JR, Reisner SA, Lichtenberg GS, Meltzer RS. Transpulmonary left ventricular contrast echocardiography using sonicated albumin in humans. Cardiovasc Tech 1990;9:405.

12. Smith MD, Elion JL McClure RR, Kwan OL, De María AN. Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. J Am Coll Cardiol 1989;13:1622-8.